Ron Cohen, President & CEO, Director at Acorda Therapeutics, holds 149.76K shares in Acorda Therapeutics (Ticker: ACOR), holds 0.00 shares in Dyax Corp (Ticker: DYAX). Most recently, Ron Cohen Bought ― shares of Acorda Therapeutics on Mar 20, 2023 for an estimated value of 12.59K.